EP2830711A4 - Verfahren und zusammensetzungen mit fgf-9 zur verbesserung der neovaskularisation und regeneration - Google Patents
Verfahren und zusammensetzungen mit fgf-9 zur verbesserung der neovaskularisation und regenerationInfo
- Publication number
- EP2830711A4 EP2830711A4 EP13770266.8A EP13770266A EP2830711A4 EP 2830711 A4 EP2830711 A4 EP 2830711A4 EP 13770266 A EP13770266 A EP 13770266A EP 2830711 A4 EP2830711 A4 EP 2830711A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- enchance
- neovascularization
- fgf
- regeneration
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261618280P | 2012-03-30 | 2012-03-30 | |
PCT/US2013/030082 WO2013148122A1 (en) | 2012-03-30 | 2013-03-09 | Methods and compositions using fgf-9 to enchance neovascularization and regeneration |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2830711A1 EP2830711A1 (de) | 2015-02-04 |
EP2830711A4 true EP2830711A4 (de) | 2015-08-26 |
Family
ID=49261002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13770266.8A Withdrawn EP2830711A4 (de) | 2012-03-30 | 2013-03-09 | Verfahren und zusammensetzungen mit fgf-9 zur verbesserung der neovaskularisation und regeneration |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2830711A4 (de) |
CA (1) | CA2869169A1 (de) |
WO (1) | WO2013148122A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015164800A2 (en) * | 2014-04-24 | 2015-10-29 | University Of Central Florida Research Foundation, Inc. | Compositions and methods for modulating polarization of monocytes |
CN104587103B (zh) * | 2014-12-04 | 2018-10-19 | 南京中医药大学 | 一种治疗出血性中风中药挥发油提取物成分群的提取方法及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010031190A1 (en) * | 2008-09-22 | 2010-03-25 | UNIVERSITé LAVAL | Culture medium for myoblasts, precursors thereof and derivatives thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7764995B2 (en) * | 2004-06-07 | 2010-07-27 | Cardiac Pacemakers, Inc. | Method and apparatus to modulate cellular regeneration post myocardial infarct |
BRPI0515588A (pt) * | 2004-09-22 | 2008-07-29 | Genzyme Corp | uso de antagonistas de tgf-beta para limitar a nefrotoxicidade de agentes imunossupressivos |
US20070065415A1 (en) * | 2005-09-16 | 2007-03-22 | Kleinsek Donald A | Compositions and methods for the augmentation and repair of defects in tissue |
EP2318016A4 (de) * | 2008-08-11 | 2012-01-18 | Univ Texas | Micro-rna als promoter von gefässintegrität und verwendung |
-
2013
- 2013-03-09 WO PCT/US2013/030082 patent/WO2013148122A1/en active Application Filing
- 2013-03-09 EP EP13770266.8A patent/EP2830711A4/de not_active Withdrawn
- 2013-03-09 CA CA2869169A patent/CA2869169A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010031190A1 (en) * | 2008-09-22 | 2010-03-25 | UNIVERSITé LAVAL | Culture medium for myoblasts, precursors thereof and derivatives thereof |
Non-Patent Citations (2)
Title |
---|
BINBIN YAN ET AL: "Transplanted Induced Pluripotent Stem Cells Improve Cardiac Function and Induce Neovascularization in the Infarcted Hearts of db/db Mice", MOLECULAR PHARMACEUTICS, vol. 8, no. 5, 3 October 2011 (2011-10-03), pages 1602 - 1610, XP055202239, ISSN: 1543-8384, DOI: 10.1021/mp2003576 * |
See also references of WO2013148122A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2013148122A1 (en) | 2013-10-03 |
CA2869169A1 (en) | 2013-10-03 |
EP2830711A1 (de) | 2015-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL285985B1 (en) | Therapeutic nuclease preparations and methods | |
IL237156A0 (en) | Microcapsule preparation and methods | |
IL252566B (en) | Pharmacy preparations and methods | |
EP2836212A4 (de) | Neuartige zusammensetzungen und verfahren | |
IL235875A0 (en) | An anti-mucus preparation based on xylitol and methods and preparations related thereto | |
EP2717926A4 (de) | Zusammensetzungen und verfahren zur prävention und behandlung von biofilmen | |
EP2849800A4 (de) | Zusammensetzungen und verfahren zur modulation der bdnf-expression | |
EP2884984A4 (de) | Therapeutische zusammensetzungen und verfahren | |
HK1214961A1 (zh) | 粘多醣病 型的鞘內注射治療的方法和組合物 | |
HK1206970A1 (en) | Antigenic compositions and methods | |
EP2931324A4 (de) | Zusammensetzungen und verfahren zur geweberegeneration | |
EP2806894A4 (de) | Verfahren und zusammensetzungen für therapeutika | |
GB201315350D0 (en) | Methods and compositions | |
GB201315347D0 (en) | Methods and compositions | |
EP2895186A4 (de) | Therapeutische zusammensetzungen und zugehörige verfahren | |
EP2870238A4 (de) | Zusammensetzungen und verfahren in zusammenhang mit viralen impfstoffen | |
EP2830711A4 (de) | Verfahren und zusammensetzungen mit fgf-9 zur verbesserung der neovaskularisation und regeneration | |
HK1231520A1 (zh) | 改進的基質穩定性組合物和方法 | |
EP2934092A4 (de) | Zusammensetzungen und verfahren zur herbeiführung einer gewünschten pflanzenwurzelbewegung | |
GB201208315D0 (en) | Pharmaceutical methods and compositions | |
HUE032878T2 (hu) | Bõrvédõ és bõrkiegyensúlyozó készítmény | |
GB201200637D0 (en) | Improvements in and relating to compositions | |
GB201205173D0 (en) | Methods and compositions relating to neurocognitive disorders | |
GB201202940D0 (en) | Improvements in or relating to dentures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20141029 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
RA4 | Supplementary search report drawn up and despatched (corrected) |
Effective date: 20150727 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 9/10 20060101AFI20150721BHEP Ipc: A61K 38/18 20060101ALI20150721BHEP Ipc: A61K 35/545 20150101ALI20150721BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20160224 |